Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-01-09 @ 11:38 AM
Study NCT ID:
NCT04225156
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-25
First Post:
2020-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-11
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-06
First Submit QC Date:
None
Study First Post Date:
2020-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-24
Last Update Post Date:
2025-09-25
Last Update Post Date Type:
ESTIMATED